$10.3 million should see ReGen Biologics through to FDA decision
This article was originally published in Clinica
Executive Summary
ReGen Biologics, a Franklin Lakes, New Jersey firm that is developing collagen implant technology for tissue repair, has raised $10.3m through a sale of common stock to new and existing investors.